Skip to main content
. Author manuscript; available in PMC: 2016 May 11.
Published in final edited form as: J Clin Immunol. 2010 Sep 28;31(1):39–50. doi: 10.1007/s10875-010-9464-8

Table I.

Clinical characteristics of SS CTCL patients.

Disease Stage No. Subjects Average Age (yrs) Gender
IA 6 59.7 1F/5M
IA/B 3 69.7 1F/2M
IB 7 60.9 2F/5M
II 2 56.0 2M
III 4 77.8 2F/2M
IV 7 70.1 3F/4M
Totals 28 65.7 9F/19M
Controls 35 59.7 13F/22M

According to the World Health Organization (WHO) and the European Organization for Research and Treatment of Cancer (EORTC) combined staging classification. Table depicts patients’ stage at the time of enrollment.